Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)

SHE:300452 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	221.15	192.69	173.96	150.12	141.26	109.32
Trading Asset Securities	475.11	515.63	511.77	214.56	187.88	191.14
Cash & Short-Term Investments	696.26	708.32	685.73	364.68	329.14	300.46
Cash Growth	6.97%	3.29%	88.03%	10.80%	9.55%	33.85%
Accounts Receivable	252.92	204.73	145.57	123.39	129.53	123.91
Other Receivables	0.9	1.05	0.59	0.59	0.26	0.74
Receivables	253.83	205.78	146.16	123.98	129.79	124.65
Inventory	81.23	88.76	94.1	91.2	77.77	48.86
Other Current Assets	23.84	18.67	13.37	51.46	16.12	16.83
Total Current Assets	1,055	1,022	939.37	631.32	552.82	490.79
Property, Plant & Equipment	469.26	476.45	503.57	439.83	305.04	322.32
Goodwill	-	-	39.13	39.13	39.13	45.26
Other Intangible Assets	56.05	51.22	52.37	53.66	54.48	36.19
Long-Term Deferred Tax Assets	5.93	5.96	5.97	12.66	8.13	4.8
Long-Term Deferred Charges	2.01	2.19	1.6	0.98	0.46	-
Other Long-Term Assets	2.09	2.37	0.71	2.97	2.52	1.51
Total Assets	1,590	1,560	1,543	1,181	962.58	900.87
Accounts Payable	159.65	186.09	219.23	225.95	132.26	122.18
Accrued Expenses	7.96	14.86	17.74	14.74	12.48	11.44
Short-Term Debt	15.3	6.46	10.01	39.84	31.04	39.99
Current Income Taxes Payable	6.37	2.13	4.07	0.04	3.12	3.91
Current Unearned Revenue	4.44	6.98	6.82	22.58	11.45	5.67
Other Current Liabilities	20.04	16.95	15.49	42.1	32.92	34.36
Total Current Liabilities	213.76	233.47	273.36	345.25	223.26	217.55
Long-Term Debt	301.35	298.51	287.59	-	-	-
Long-Term Unearned Revenue	35	33.49	35	31.13	27.76	22.97
Long-Term Deferred Tax Liabilities	18.06	18.95	11.51	15.56	5.64	5.18
Total Liabilities	568.17	584.43	607.46	391.93	256.67	245.7
Common Stock	234.45	234.45	234.46	234.52	180.47	180.47
Additional Paid-In Capital	65.51	65.51	65.58	65.81	65.64	61.8
Retained Earnings	639.33	592.15	530.88	427.94	405.45	361.3
Treasury Stock	-22.51	-22.51	-0.21	-5.83	-12.13	-20.08
Comprehensive Income & Other	35.72	35.41	35.39	0.07	0.57	1.72
Total Common Equity	952.51	905.01	866.09	722.52	640	585.21
Minority Interest	69.81	70.29	69.15	66.1	65.92	69.97
Shareholders' Equity	1,022	975.3	935.25	788.62	705.92	655.17
Total Liabilities & Equity	1,590	1,560	1,543	1,181	962.58	900.87
Total Debt	316.65	304.98	297.6	39.84	31.04	39.99
Net Cash (Debt)	379.6	403.35	388.13	324.84	298.11	260.46
Net Cash Growth	8.16%	3.92%	19.48%	8.97%	14.45%	22.05%
Net Cash Per Share	1.60	1.72	1.61	1.39	1.27	1.13
Filing Date Shares Outstanding	235.88	243.69	237.2	223.93	237.49	220.01
Total Common Shares Outstanding	235.88	243.69	237.2	223.93	237.49	220.01
Working Capital	841.4	788.06	666.01	286.07	329.56	273.24
Book Value Per Share	4.04	3.71	3.65	3.23	2.69	2.66
Tangible Book Value	896.46	853.79	774.6	629.73	546.39	503.76
Tangible Book Value Per Share	3.80	3.50	3.27	2.81	2.30	2.29
Buildings	-	-	236.38	180.15	176.81	181.3
Machinery	-	-	289.19	214.45	204.84	198.84
Construction In Progress	-	-	86.49	154.59	6.49	6.91

Updated Oct 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.